Results 221 to 230 of about 2,211,291 (297)

Changes in lower urinary tract symptoms and uroflowmetric parameters after CPAP therapy in patients with obstructive sleep apnea syndrome and benign prostatic hyperplasia: A retrospective study. [PDF]

Medicine (Baltimore)
İncekara Y, Erbay G, Çiçek S, Şanli A, Kiliçarslan M.   +4 more
europepmc   +1 more source

Predictors of pain improvement with Kampo formulas after UPOINT-guided management in chronic pelvic pain syndrome: a retrospective cohort study. [PDF]

Front Pharmacol
Kitano H, Ogawa-Ochiai K, Ueno R, Okazaki M, Yukihiro K, Hatayama T, Shikuma H, Nakano Y, Tasaka S, Iwane K, Tasaka R, Kohada Y, Miyamoto S, Naito M, Kobatake K, Sekino Y, Goto K, Hieda K, Hinata N.   +18 more
europepmc   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

BMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu, Xuejian Wang, Wenyan Jiang, Wan Hairul Anuar Kamaruddin, Chunyan Fang, Pengfei Zhang   +5 more
wiley   +1 more source

In-Depth optimization and characterization of prostatic and penile vessel imaging with Ferumoxytol-enhanced magnetic resonance imaging. [PDF]

Med Phys
Fang D, McWIlliams J, Wang C, Maziero D, Iwamoto KS, Kishan AU, Finn JP, Zhong X, Ruan D.   +8 more
europepmc   +1 more source

Prostatic diseases (Client information series)

, 2004
Francey, Thierry
core  

Metal nanostructure‐coupled label‐free localized surface plasmon resonance biosensors for rapid and sensitive disease diagnosis

BMEMat, EarlyView.
LSPR biosensing enables rapid, sensitive, and low‐sample‐volume detection of biomarkers, with broad applications in diagnosing cancer, infectious, and chronic diseases. Advances in nanostructure design, micro/nanofabrication, and microfluidic integration have expanded the potential of LSPR sensors in biomedical diagnostics.
Zhaoxin Geng, Yunfei Sha, Jiongyan Yang, Hongru Yang, Xiao Liang   +4 more
wiley   +1 more source

Perioperative outcomes and prevalence of urethral strictures during surgery for benign prostatic hyperplasia: results from the GRAND study. [PDF]

World J Urol
Pyrgidis N, Schulz GB, Weinhold P, Volz Y, Atzler M, Stadelmeier LF, Papadopoulos I, Stief C, Marcon J, Keller P.   +9 more
europepmc   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

BMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo, Shun Yao, Lihui Meng, Chunyuan Chen, Yuechu Lucinda Lu, Rong Lu, Kashif Rafiq Zahid, Umar Raza, Qingzhi Wu, Wenli Chen   +9 more
wiley   +1 more source

Antifibrotic therapy for Lower Urinary Tract Symptoms secondary to Benign Prostatic Hyperplasia. [PDF]

Prostate Cancer Prostatic Dis
Limkar AR, McVary KT, Ricke WA, Lee MS.
europepmc   +1 more source

Nanomedicine‐driven innovations in postoperative cancer immunotherapy: Remodeling tumor microenvironment and precision delivery strategies

BMEMat, EarlyView.
Nanomedicine‐Driven Strategies for Suppressing Postoperative Tumor Recurrence. This schematic illustrates three pivotal nanomedical strategies that synergistically counteract recurrence by targeting residual disease and the immunosuppressive tumor microenvironment within the surgical cavity.
Lisong Pang, Zhuomin Wang, Zhenhua Jin, Ahmed H. Ghonaim, Hengcheng Zhang, Xinyu You, Jinzhuo Ning, Jiaqing Cao, Yang Liu   +8 more
wiley   +1 more source